Allorion Therapeutics

Allorion

This biotechnology company develops small-molecule drugs for patients with cancer and autoimmune diseases using its proprietary drug discovery platforms.

Auron Therapeutics

This company develops small-molecule drugs using an AI-powered platform to treat patients with cancer and inflammatory diseases.

BlossomHill Therapeutics

This biopharmaceutical company develops small molecule medicines to treat patients with various forms of cancer and autoimmune disorders.

HotSpot Therapeutics

The company develops allosteric small molecule medicines for patients with cancer and autoimmune diseases by targeting natural regulatory pockets on proteins.

Graviton Bioscience Corporation

The company develops small-molecule therapeutics targeting autoimmune, fibrotic and central nervous system diseases for patients with unmet medical needs.

KyDo Therapeutics

This company develops covalent-allosteric small molecule inhibitors for the treatment of challenging cancer variants within the oncology sector.

Odyssey Therapeutics

This biopharmaceutical company develops oral small molecule and protein medicines for patients with autoimmune and inflammatory diseases.

Attovia Therapeutics

The company develops biparatopic biologics to treat patients with immune-mediated diseases and cancer through a modular protein design platform.